Skip to content

Clinical trials

Phase 3 Acquired Immunodeficiency Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 3 Country / region: United States Clear all

138 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20031
20044
20051
20063
20074
20085
20095
20102
201110
20125
20133
20142
20152
20164
20182
20201
20213
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed123
Terminated5
Active, not recruiting3
Recruiting2
Withdrawn2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)36
ViiV Healthcare16
Gilead Sciences10
Bristol-Myers Squibb7
Glaxo Wellcome5
Hoffmann-La Roche5
Pfizer5
Sequus Pharmaceuticals4
Tibotec Pharmaceuticals, Ireland4
GlaxoSmithKline3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome138
HIV Infections105
AIDS-Related Complex27
Pneumonia, Pneumocystis18
AIDS-Related Opportunistic Infections15
Infections12
Sarcoma, Kaposi6
Cytomegalovirus Infections5
Mycobacterium avium-intracellulare Infection5
Cytomegalovirus Retinitis3

Trials

Showing 1 to 25 of 138. Each trial links to its page on Pharma Observatory.

38 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.